Herpes zoster in older adults: Impact on carbon footprint in the United States
- PMID: 38698759
- PMCID: PMC11073404
- DOI: 10.1080/21645515.2024.2335722
Herpes zoster in older adults: Impact on carbon footprint in the United States
Abstract
We provide estimates for (I) annual herpes zoster (HZ) cases, (II) carbon costs related to healthcare utilization, and (III) annual carbon emissions due to HZ among ≥50 years of age (YOA) United States (US) population. We estimated the annual number of HZ cases in the US based on available incidence data and demographic data of individuals ≥50 YOA. Both the healthcare resource utilization (HCRU) associated with HZ cases and the unit carbon dioxide equivalent (i.e. CO2e) costs associated with each type of HCRU in the US were estimated based on literature and studies available online. The carbon footprint associated with HZ annually among US adults ≥50 YOA was estimated by multiplying the unit carbon estimates by the HCRU. In the US population aged ≥50 YOA in 2020 (i.e. approximately 118 million), approximately 1.1 million cases of HZ occur annually assuming no vaccination. Based on 2 sources of HCRU the average kgCO2e per HZ patient ranged from 61.0 to 97.6 kgCO2e, with values by age group ranging from 40.9 kgCO2e in patients aged 50-59 to 195.9 kgCO2e in patients ≥80 YOA. The total annual HZ associated carbon ranged between 67,000 and 107,000 tons of CO2e in the US population aged ≥50 YOA. The impact of HZ on carbon footprint in the US results in considerable greenhouse gas (GHG)emissions. Assuming no vaccination, the burden of HZ is projected to rise over the coming years with the aging populations consequently worsening its impact on GHG emissions. (Figure 1).
Keywords: Herpes zoster; climate change; environmental sustainability; healthcare resource.
Conflict of interest statement
DC, JB and SW are employed by/hold shares in GSK. JB declares participation on a Data Safety Monitoring Board/Advisory Board and financial services from GSK, outside of the submitted work. IC is an employee of Carbon Trust, who was engaged by GSK to complete part of the work related to this manuscript. All authors declare no other financial and non-financial relationships and activities.
Figures
Similar articles
-
Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis.BMJ Open. 2019 Aug 27;9(8):e023502. doi: 10.1136/bmjopen-2018-023502. BMJ Open. 2019. PMID: 31462457 Free PMC article.
-
Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany.Hum Vaccin Immunother. 2021 Dec 2;17(12):5296-5303. doi: 10.1080/21645515.2021.2002085. Epub 2021 Dec 14. Hum Vaccin Immunother. 2021. PMID: 34905463 Free PMC article.
-
Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study.Hum Vaccin Immunother. 2024 Dec 31;20(1):2348839. doi: 10.1080/21645515.2024.2348839. Epub 2024 May 28. Hum Vaccin Immunother. 2024. PMID: 38804600 Free PMC article.
-
A systematic literature review to assess the burden of herpes zoster disease in China.Expert Rev Anti Infect Ther. 2021 Feb;19(2):165-179. doi: 10.1080/14787210.2020.1792290. Epub 2020 Sep 30. Expert Rev Anti Infect Ther. 2021. PMID: 32997550
-
Vaccination: a new option to reduce the burden of herpes zoster.Expert Rev Vaccines. 2010 Mar;9(3 Suppl):31-5. doi: 10.1586/erv.10.32. Expert Rev Vaccines. 2010. PMID: 20192716 Review.
References
-
- Costello A, Abbas M, Allen A, Ball S, Bell S, Bellamy R, Friel S, Groce N, Johnson A, Kett M, et al. Managing the health effects of climate change: lancet and University College London Institute for Global health Commission. Lancet. 2009;373(9676):1693–7. doi:10.1016/S0140-6736(09)60935-1. - DOI - PubMed
-
- World Health Organization . Climate change: an opportunity for public health; 2014. [accessed 2023 Jan 17]. https://www.who.int/news-room/commentaries/detail/climate-change-an-oppo....
-
- Tennison I, Roschnik S, Ashby B, Boyd R, Hamilton I, Oreszczyn T, Owen A, Romanello M, Ruyssevelt P, Sherman JD, et al. Health care’s response to climate change: a carbon footprint assessment of the NHS in England. Lancet Planet Health. 2021;5(2):84–92. doi:10.1016/S2542-5196(20)30271-0. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical